Search academic texts

Information × Registration Number 0301U002106, 0196U013953 , R & D reports Title Examination of influence of low mollecular heparin on clinical symptoms, immune system, coagulation and fibrinolisis of the patients suffering on ocute forms of ischemic heart disease popup.stage_title Вивчити вплив низькомолекулярного гепарину (фраксипарину) на клінічний перебіг, систему імунітету, зсідання крові і фібриноліз у хворих з гострими формами ішемічної хвороби серця Head Zaremba Ye.F., Registration Date 07-02-2001 Organization Danylo Halytsky Lviv state medical university popup.description2 We have examined 160 patients suffering from acute myocardial infarction (MI) and 50 patients with unstable angina pectoris (AP). The influence of low molecular heparin on clinical symptoms, immune system, coagulation and fibrinlysis was investigated. A new method of treatment which is based on using of low doses of Fraxiparin (0,3 ml once a day during 7 days) in patients with MI and AP was developed. It allows to reduce the cost of treatment and to cut down the stay in hospital by 2 or 3 days Product Description popup.authors popup.nrat_date 2020-04-02 Close